Ajay Nayak & George Hodgin, Academic and Business Perspectives of Compliance in Cannabis Research

May 2021

George Hodgin

Title: Access to Federally Compliant Cannabis for Research
George Hodgin is the Founder and CEO of Biopharmaceutical Research Company (BRC), an applicant with the Drug Enforcement Administration to produce federally compliant cannabis products for research. BRC holds several DEA Schedule I Registrations and engages in compliant cannabis research. He is a former Navy SEAL officer and alumnus of the Stanford University Graduate School of Business. He was commissioned as an officer in the Navy in 2009, after earning a BA in Economics and Mandarin from the University of North Carolina at Chapel Hill, where he was a Morehead-Cain scholar. George led SEALs in combat in counter-terrorism operations in Afghanistan and Southeast Asia. His hobbies include fly-fishing and hiking with his family and dog. He and his wife and two sons live in Carmel-By-the-Sea, California.

Ajay Nayak

Title: Navigating through cannabis research: an academic story of partnerships and collaborations
Ajay Nayak is an Assistant Professor in the Department of Medicine at Thomas Jefferson University, Philadelphia. He has an appointment in the Center for Translational Medicine and the Division of Pulmonary, Allergy and Critical Care Medicine at TJU. Ajay received his B.Sc. and M. Sc. In Microbiology from the University of Mumbai and came to the US in 2006 to pursue his doctoral degree from West Virginia University. Ajay was a civilian employee with the Federal government at CDC/NIOSH in Morgantown, WV. Ajay has been actively involved in cannabis research efforts for almost a decade. His primary areas of interest in the field of allergy. He is also interested in examining the physiological and pathophysiological effects of cannabis on human health. He is engaged in multiple collaborations both nationally and internationally to further cannabis research. His lab has an active research grant from NIH to develop diagnostic tools for determining cannabis allergies.

Previous Webinars

Joshua Kellogg, PhD.

Wed, Oct. 16, 11:00AM MST

Cannabinoids: From the Plant to the Gut

Dr. Joshua Kellogg is an Assistant Professor at the Pennsylvania State University, where his lab employs transdisciplinary approaches at the interface of analytical chemistry, chemical biology, natural product chemistry, and molecular biology to further human, plant, animal, and environmental health. His team works to […]

Read More »

Godfrey Pearlson, PHD.

10 October 2024, 1:00PM MST

Cannabis and driving: knowns and known unknowns

Dr. Pearlson’s medical training was at the University of Newcastle upon Tyne in England. Following internship he completed a graduate degree in philosophy at Columbia University in New York and was then successively a resident, postdoctoral fellow and faculty member at Johns Hopkins […]

Read More »

Suman Chandra, MPhil, PhD.

18 September 2024, 11:AM MST

Cannabis: An Old Plant with New Horizons, Botany and Biomass Production for the Drug Development

Dr. Chandra earned his M.Phil. degree in Environmental Plant Physiology and his Ph.D. in Plant Physiology from The High Altitude Plant Physiology Research Center, HNB Garhwal University (A Central University), India. From 1992 to 2000, […]

Read More »

Carrie Cuttler, PHD.

12 September 2024, 1:00PM MST

Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition

Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]

Read More »

Dmitry Kurouski, PhD

Raman spectroscopy-assisted diagnosis of cannabis physiological differences

Dmitry Kurouski earned his MS in Biochemistry from Belarusian State University, Belarus and PhD (Distinguished Dissertation) in Analytical Chemistry from SUNY Albany, NY, USA. After a Postdoc in the laboratory of Professor Richard P. Van Duyne at Northwestern University, Dr Kurouski joined BoehringerIngelheim Pharmaceuticals, where he worked […]

Read More »

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »